Emerging mobile health technologies need FDA oversight

Smart phones and other mobile devices have the potential to transform healthcare, improving medical outcomes, reducing errors, and broadening access to healthcare. The Food and Drug Administration must continue to have jurisdiction over these “mobile health” or “mHealth” innovations to address emerging risks, according to I. Glenn Cohen, Nathan G. Cortez, and Aaron S. Kesselheim, […]